Search research articles
Contact Us
Filters
Showing results (51-60 of 155) with videos related to
Page
of 16
Sort By:
Alimentary Pharmacology & Therapeutics
|
April 26, 2022
Letter: long-term colorectal cancer incidence and mortality after adenoma removal associated with heritable factors, colonoscopic surveillance and aspirin-authors' reply
Henriette C Jodal, Michael Bretthauer, Mette Kalager, et al.
BMJ (Clinical Research Ed.)
|
November 20, 2012
Prognosis in women with interval breast cancer: population based observational cohort study
Mette Kalager, Rulla M Tamimi, Michael Bretthauer, et al.
The New England Journal of Medicine
|
November 23, 2012
Clinical decisions. Mammography screening for breast cancer
Robert A Smith, Karla Kerlikowske, Diana L Miglioretti, et al.
Annals of Internal Medicine
|
October 13, 2025
When Would You Screen This 39-Year-Old Woman for Breast Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Zahir Kanjee, John B Wong, Mette Kalager, et al.
EGEMS (Washington, DC)
|
November 29, 2016
Comparative Effectiveness Research Using Observational Data: Active Comparators to Emulate Target Trials with Inactive Comparators
Anders Huitfeldt, Miguel A Hernan, Mette Kalager, et al.
Annals of Internal Medicine
|
November 7, 2018
Long-Term Effectiveness of Sigmoidoscopy Screening in Women and Men
Øyvind Holme, Magnus Løberg, Mette Kalager, et al.
Annals of Internal Medicine
|
April 5, 2012
Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program
Mette Kalager, Hans-Olov Adami, Michael Bretthauer, et al.
Annals of Internal Medicine
|
October 4, 2017
Breast Cancer Screening in Denmark
Karsten Juhl Jørgensen, Peter C Gøtzsche, Mette Kalager, et al.
Annals of Internal Medicine
|
January 24, 2017
Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis
Karsten Juhl Jørgensen, Peter C Gøtzsche, Mette Kalager, et al.
Lancet (London, England)
|
January 17, 2021
Deep learning and cancer biomarkers: recognising lead-time bias
Michael Bretthauer, Magnus Løberg, Øyvind Holme, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 155) with videos related to
Sort By:
Page
of 16
Alimentary Pharmacology & Therapeutics
|
April 26, 2022
Letter: long-term colorectal cancer incidence and mortality after adenoma removal associated with heritable factors, colonoscopic surveillance and aspirin-authors' reply
Henriette C Jodal, Michael Bretthauer, Mette Kalager, et al.
BMJ (Clinical Research Ed.)
|
November 20, 2012
Prognosis in women with interval breast cancer: population based observational cohort study
Mette Kalager, Rulla M Tamimi, Michael Bretthauer, et al.
The New England Journal of Medicine
|
November 23, 2012
Clinical decisions. Mammography screening for breast cancer
Robert A Smith, Karla Kerlikowske, Diana L Miglioretti, et al.
Annals of Internal Medicine
|
October 13, 2025
When Would You Screen This 39-Year-Old Woman for Breast Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Zahir Kanjee, John B Wong, Mette Kalager, et al.
EGEMS (Washington, DC)
|
November 29, 2016
Comparative Effectiveness Research Using Observational Data: Active Comparators to Emulate Target Trials with Inactive Comparators
Anders Huitfeldt, Miguel A Hernan, Mette Kalager, et al.
Annals of Internal Medicine
|
November 7, 2018
Long-Term Effectiveness of Sigmoidoscopy Screening in Women and Men
Øyvind Holme, Magnus Løberg, Mette Kalager, et al.
Annals of Internal Medicine
|
April 5, 2012
Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program
Mette Kalager, Hans-Olov Adami, Michael Bretthauer, et al.
Annals of Internal Medicine
|
October 4, 2017
Breast Cancer Screening in Denmark
Karsten Juhl Jørgensen, Peter C Gøtzsche, Mette Kalager, et al.
Annals of Internal Medicine
|
January 24, 2017
Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis
Karsten Juhl Jørgensen, Peter C Gøtzsche, Mette Kalager, et al.
Lancet (London, England)
|
January 17, 2021
Deep learning and cancer biomarkers: recognising lead-time bias
Michael Bretthauer, Magnus Løberg, Øyvind Holme, et al.
Page
of 16